Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F C Jensen

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Hybridoma|January 1, 1984
Production and characterization of monoclonal antibody to gentamicinJ D Place, S G Thompson, J F Burd, et al.
Nature|June 20, 1985
Human T-cell lymphotropic virus type-I antibodies in Falashas and other ethnic groups in IsraelZ Ben-Ishai, M Haas, D Triglia, et al.
The Journal of Experimental Medicine|October 1, 1981
Low-calorie diet selectively reduces expression of retroviral envelope glycoprotein gp70 in sera of NZB x NZW F1 hybrid miceS Izui, G Fernandes, I Hara, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1977
Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinantsJ H Elder, J W Gautsch, F C Jensen, et al.
Cancer Research|January 1, 1982
Induction of lymphoma in antigenically stimulated athymic miceS M Baird, G M Beattie, R A Lannom, et al.
AIDS (London, England)|January 11, 2000
Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogenR B Moss, W K Giermakowska, M R Wallace, et al.
Clinical and Experimental Immunology|June 26, 2001
Expression of perforin on HIV-1-specific CD8+ lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogenR B Moss, W K Giermakowska, M R Wallace, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1991
Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzeesC J Gibbs, R Peters, M Gravell, et al.
Clinical and Experimental Immunology|June 1, 1993
T cell receptor V beta repertoire in HIV-infection individuals: lack of evidence for selective V beta deletionV Boyer, L R Smith, F Ferre, et al.
AIDS Patient Care and Stds|December 1, 1996
Combination therapies against HIV-1 infection: exploring the concept of combining antiretroviral drug treatments with HIV-1 immune-based therapies in asymptomatic individualsF Ferre, R B Moss, A E Daigle, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Hybridoma|January 1, 1984
Production and characterization of monoclonal antibody to gentamicinJ D Place, S G Thompson, J F Burd, et al.
Nature|June 20, 1985
Human T-cell lymphotropic virus type-I antibodies in Falashas and other ethnic groups in IsraelZ Ben-Ishai, M Haas, D Triglia, et al.
The Journal of Experimental Medicine|October 1, 1981
Low-calorie diet selectively reduces expression of retroviral envelope glycoprotein gp70 in sera of NZB x NZW F1 hybrid miceS Izui, G Fernandes, I Hara, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 1, 1977
Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinantsJ H Elder, J W Gautsch, F C Jensen, et al.
Cancer Research|January 1, 1982
Induction of lymphoma in antigenically stimulated athymic miceS M Baird, G M Beattie, R A Lannom, et al.
AIDS (London, England)|January 11, 2000
Cell-mediated immune responses to autologous virus in HIV-1-seropositive individuals after treatment with an HIV-1 immunogenR B Moss, W K Giermakowska, M R Wallace, et al.
Clinical and Experimental Immunology|June 26, 2001
Expression of perforin on HIV-1-specific CD8+ lymphocytes after immunization with a gp120-depleted, whole-killed HIV-1 immunogenR B Moss, W K Giermakowska, M R Wallace, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1991
Observations after human immunodeficiency virus immunization and challenge of human immunodeficiency virus seropositive and seronegative chimpanzeesC J Gibbs, R Peters, M Gravell, et al.
Clinical and Experimental Immunology|June 1, 1993
T cell receptor V beta repertoire in HIV-infection individuals: lack of evidence for selective V beta deletionV Boyer, L R Smith, F Ferre, et al.
AIDS Patient Care and Stds|December 1, 1996
Combination therapies against HIV-1 infection: exploring the concept of combining antiretroviral drug treatments with HIV-1 immune-based therapies in asymptomatic individualsF Ferre, R B Moss, A E Daigle, et al.
Pageof 6